| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of TREVENA INC by Trevena, Inc. (OTCEM:TRVN) through any online brokerage.
There are no as such competitors for TREVENA INC by Trevena, Inc..
TREVENA INC by Trevena, Inc. has a consensus price target of $5.00.
The stock price for TREVENA INC by Trevena, Inc. (OTCEM: TRVN) is $0.015 last updated November 28, 2025 at 1:01 PM EST.
There are no upcoming dividends for TREVENA INC by Trevena, Inc..
TREVENA INC by Trevena, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for TREVENA INC by Trevena, Inc..
TREVENA INC by Trevena, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
